Simulations Plus (SLP) Getting Somewhat Favorable Press Coverage, Analysis Shows
Media coverage about Simulations Plus (NASDAQ:SLP) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Simulations Plus earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave media coverage about the technology company an impact score of 45.6126410850418 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the headlines that may have effected Accern’s analysis:
- Contrasting Simulations Plus (SLP) and HealthEquity (HQY) (americanbankingnews.com)
- Simulations Plus Launches New Divisions (sfvbj.com)
- Zacks: Analysts Set $17.35 Target Price for Simulations Plus, Inc. (SLP) (americanbankingnews.com)
- Simulations Plus Announces Senior Management Changes (finance.yahoo.com)
A number of equities analysts recently commented on SLP shares. Zacks Investment Research upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating and set a $17.00 target price for the company in a research note on Tuesday, July 25th. BidaskClub downgraded shares of Simulations Plus from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st.
Simulations Plus (NASDAQ:SLP) opened at 14.95 on Thursday. Simulations Plus has a 1-year low of $8.10 and a 1-year high of $16.15. The firm has a 50-day moving average of $14.62 and a 200 day moving average of $12.37. The firm has a market cap of $257.81 million, a P/E ratio of 47.46 and a beta of -0.71.
Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Friday, July 14th. The technology company reported $0.13 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.02. Simulations Plus had a net margin of 30.82% and a return on equity of 33.99%. The company had revenue of $6.75 million for the quarter, compared to the consensus estimate of $6.48 million. On average, analysts predict that Simulations Plus will post $0.32 EPS for the current year.
In other Simulations Plus news, CEO Walter S. Woltosz sold 18,500 shares of the business’s stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $15.07, for a total transaction of $278,795.00. Following the sale, the chief executive officer now directly owns 5,684,916 shares in the company, valued at approximately $85,671,684.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 36.93% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://theolympiareport.com/2017/09/07/simulations-plus-slp-getting-somewhat-favorable-press-coverage-analysis-shows.html.
Simulations Plus Company Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.